tiprankstipranks
Trending News
More News >
Advertisement

QQQE - ETF AI Analysis

Compare

Top Page

QQQE

Direxion NASDAQ-100 Equal Weighted Index Shares (QQQE)

Rating:71Outperform
Price Target:
The ETF QQQE has a solid overall rating, reflecting a balanced mix of strong-performing holdings and some weaker contributors. Regeneron (REGN) stands out as a key driver of the fund's rating due to its impressive financial health, revenue growth, and strategic investments in research and development. On the other hand, Intel (INTC) has a notably lower score, weighed down by profitability challenges and overvaluation concerns, which may slightly dampen the ETF's overall performance. Investors should also consider the fund's exposure to potential risks, such as concentration in AI-driven sectors and international market challenges.
Positive Factors
Strong Top Holdings
Several top holdings, such as Micron and Lam Research, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including technology, consumer cyclical, and health care, reducing reliance on any single industry.
Reasonable Expense Ratio
The ETF has a relatively low expense ratio, making it cost-effective compared to many actively managed funds.
Negative Factors
Overweight in Technology
With over 40% of the portfolio in technology, the ETF is heavily exposed to potential volatility in this sector.
Underperforming Holdings
Some holdings, like Trade Desk and Marvell, have shown weak year-to-date performance, which could drag on overall returns.
Limited Geographic Exposure
The ETF is highly concentrated in U.S. companies, offering minimal diversification across international markets.

QQQE vs. SPDR S&P 500 ETF (SPY)

QQQE Summary

The Direxion NASDAQ-100 Equal Weighted Index Shares (Ticker: QQQE) is an ETF that gives investors exposure to the NASDAQ-100 Index but with a unique twist: it allocates equal weight to all 100 companies in the index. This means that every company, big or small, has the same impact on the fund’s performance, promoting diversification. It includes well-known companies like Intel and Advanced Micro Devices (AMD) and focuses on large-cap stocks across sectors like technology, healthcare, and consumer services. Investors might consider QQQE for balanced exposure to high-growth industries and reduced concentration in mega-cap tech stocks. However, since it tracks the NASDAQ-100, its performance can fluctuate with the overall market, especially if tech stocks face challenges.
How much will it cost me?The expense ratio for QQQE is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because QQQE is an equal-weighted fund, which requires more active management compared to passively managed funds that track market-cap weighted indexes.
What would affect this ETF?QQQE’s exposure to technology and consumer sectors positions it to benefit from innovation and growth in these areas, especially as demand for tech products and services continues to rise. However, the fund could face challenges if interest rates increase, as higher borrowing costs can impact growth-focused companies, or if regulatory changes affect major tech firms. Its equal-weighted approach reduces concentration risk but may limit gains during periods when mega-cap stocks outperform.

QQQE Top 10 Holdings

The QQQE ETF’s equal-weighted approach gives every stock in the NASDAQ-100 a fair shot at driving performance, but recent results show mixed momentum across key names. Micron is rising steadily, buoyed by its strategic focus on AI and data centers, while Warner Bros. Discovery is gaining traction thanks to streaming growth and box office success. On the other hand, AMD has been lagging, as valuation concerns and technical signals weigh on its outlook. With a heavy tilt toward technology and healthcare, the fund remains concentrated in sectors that thrive on innovation, offering a balanced yet dynamic exposure to U.S. large-cap stocks.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Applied Materials1.38%$17.07M$214.65B56.62%
77
Outperform
Micron1.36%$16.78M$255.06B124.70%
77
Outperform
Advanced Micro Devices1.34%$16.53M$351.62B52.79%
74
Outperform
Intel1.33%$16.50M$193.19B94.71%
64
Neutral
Marvell1.29%$15.93M$83.27B-13.39%
76
Outperform
Intuitive Surgical1.26%$15.62M$201.58B3.83%
78
Outperform
Biogen1.24%$15.39M$26.70B14.26%
74
Outperform
Warner Bros1.24%$15.30M$60.81B129.78%
70
Outperform
Lam Research1.21%$14.91M$197.31B108.87%
77
Outperform
Regeneron1.19%$14.71M$75.97B-5.87%
78
Outperform

QQQE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
101.95
Positive
100DMA
100.31
Positive
200DMA
95.73
Positive
Market Momentum
MACD
0.26
Negative
RSI
59.65
Neutral
STOCH
96.69
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QQQE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 100.96, equal to the 50-day MA of 101.95, and equal to the 200-day MA of 95.73, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 59.65 is Neutral, neither overbought nor oversold. The STOCH value of 96.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QQQE.

QQQE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.23B0.35%
$9.13B0.07%
$8.47B0.34%
$8.15B0.52%
$8.01B0.61%
$1.89B0.55%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QQQE
Direxion NASDAQ-100 Equal Weighted Index Shares
103.59
8.31
8.72%
MGC
Vanguard Mega Cap ETF
PRF
Invesco FTSE RAFI US 1000 ETF
FTCS
First Trust Capital Strength ETF
QYLD
Global X NASDAQ 100 Covered Call ETF
QQEW
First Trust Nasdaq-100 Equal Weighted Index Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement